Literature DB >> 20392237

Purification and identification of estrogen receptor alpha co-regulators in osteoclasts.

Ichiro Takada1, Naoya Tsuji, Min-Young Youn, Sally Fujiyama, Maiko Okada, Yuuki Imai, Shino Kondo, Hirochika Kitakawa, Hisataka Yasuda, Shigeaki Kato.   

Abstract

Mature osteoclasts are multinuclear, macrophage-like cells derived from hematopoietic stem cells in the bone marrow. Several transcription factors regulating osteoclast differentiation have been identified. However, the molecular basis of transcriptional regulation in osteoclasts at epigenetic levels is largely unknown. In fact, no osteoclast-specific transcriptional co-regulators have been characterized. Recently, selective ablation of estrogen receptor alpha (ERalpha) in mature osteoclasts derived from female mice (ERalpha(Deltaoc/Deltaoc)) exhibited trabecular bone loss due to induced apoptosis via upregulated expression of Fas ligand mRNA. In general, the component composition of the ERalpha-associated co-activator complex and its expression levels are distinct among tissues. However, ERalpha transcriptional co-regulators in mature osteoclasts remain unclear. In the present study, we achieved large-scale cultivation of mature, multinucleated osteoclasts and established a purification system for ERalpha-associated proteins. In addition to co-regulators previously found in other ERalpha target cells, several unexpected factors were found such as CAP-H. The mRNA expression level of CAP-H was high during osteoclast differentiation. These results demonstrate the existence of osteoclast-specific transcriptional co-regulators supporting ERalpha function.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20392237     DOI: 10.1111/j.1749-6632.2009.05215.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  2 in total

1.  DGCR14 induces Il17a gene expression through the RORγ/BAZ1B/RSKS2 complex.

Authors:  Ichiro Takada
Journal:  Mol Cell Biol       Date:  2014-11-03       Impact factor: 4.272

2.  Pharmacological estrogen administration causes a FSH-independent osteo-anabolic effect requiring ER alpha in osteoblasts.

Authors:  Sebastian Seitz; Johannes Keller; Arndt F Schilling; Anke Jeschke; Robert P Marshall; Brenda D Stride; Tim Wintermantel; Frank T Beil; Michael Amling; Günther Schütz; Jan Tuckermann; Thorsten Schinke
Journal:  PLoS One       Date:  2012-11-27       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.